Form 8-K

8-K — Caring Brands, Inc.

Accession: 0001493152-26-036419

Filed: 2026-08-06

Period: 2026-08-06

CIK: 0002020737

SIC: 2844 (PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS)

Item: Other Events

Item: Financial Statements and Exhibits

Documents

8-K — form8-k.htm (Primary)

EX-99.1 (ex99-1.htm)

GRAPHIC (ex99-1_001.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: form8-k.htm · Sequence: 1

false

0002020737

2026-08-06

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

WASHINGTON,

D.C. 20549

FORM

8-K

CURRENT

REPORT

PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES

EXCHANGE ACT OF 1934

Date

of Report (Date of earliest event reported): August 6, 2026

Caring

Brands, Inc.

(Exact

name of registrant as specified in its charter)

Nevada

001-42941

99-4103908

(State

or other jurisdiction

incorporation)

(Commission

File

Number)

(IRS

Employer

Identification

No.)

130

S Indian River Drive,

Suite

202 pbm# 1232,

Fort

Pierce, FL 34950

(Address

of principal executive offices, including zip code)

Registrant’s

telephone number, including area code: (561) 896-7616

Not

Applicable

(Former

name or former address, if changed since last report)

Check

the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under

any of the following provisions:

☐

Written communications

pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant

to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications

pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications

pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities

registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

Symbol(s)

Name

of each exchange on which registered

Common

Stock, par value $0.001 per share

CABR

The

Nasdaq Stock Market LLC

Indicate

by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405

of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ☒

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

8.01 Other Events.

August 6, 2026, Caring Brands, Inc., a Nevada corporation, (the “Company”), issued a press release providing an update

regarding its issued United States patent portfolio covering the Company’s Hair Enzyme Booster and Photocil product platforms,

and related matters. A copy of the press release is filed as Exhibit 99.1 to this Current Report and incorporated herein by reference.

Item

9.01 Financial Statements and Exhibits.

(d)

Exhibits

The

following exhibits are being filed herewith:

Exhibit

No.

Description

99.1

Press Release, dated August 6, 2026

104

Cover Page Interactive

Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned hereunto duly authorized.

Dated: August 6, 2026

Caring Brands, Inc.

By:

/s/ Glynn

Wilson

Name:

Dr. Glynn Wilson

Title:

Chief Executive Officer

EX-99.1

Filename: ex99-1.htm · Sequence: 2

Exhibit

99.1

Caring

Brands Provides Intellectual Property Portfolio Update

Commercial

Patent Portfolio Includes Five Issued U.S. Patents Protecting Core Flagship Platforms Targeting $20B+ Combined Global Dermatology &

Hair Care Markets

Fort

Pierce, FL (GLOBE NEWSWIRE – August 6, 2026) – Caring Brands Inc. (Nasdaq: CABR) a wellness consumer-products company,

today provided an update on its expanding intellectual property (IP) portfolio, which now includes five issued U.S. patents covering

two of the Company’s principal product platforms: Hair Enzyme Booster and Photocil.

Four

of the issued patents cover Hair Enzyme Booster, while the fifth supports Photocil. Together, these patents establish a strong IP moat

supporting Caring Brands’ licensing-led commercialization strategy and ongoing strategic partner discussions. Additional U.S. and

international patent applications remain in active prosecution across multiple countries.

Key

Product Platforms & Market Opportunities

Hair

Enzyme Booster ($1.8B+ Market Opportunity): Covered by a four-patent family protecting compositions and methods relating to sulfotransferase

enzyme activity and minoxidil metabolism. Up to 50% to 60% of minoxidil users fail to see optimal results due to low baseline scalp enzyme

levels. Designed for use alongside topical minoxidil, Hair Enzyme Booster optimizes the enzymatic environment to boost activity, directly

addressing an estimated 80+ million hair loss sufferers in the U.S. alone.

Photocil

($20B+ Dermatology Market Opportunity): Covered by an issued U.S. patent protecting methods and compositions involving selective transmission

and filtration of specific ultraviolet (UV) light wavelengths. Photocil functions as a topical narrow-band UV filter engineered for targeted

skin health applications, addressing global patient populations of over 125 million psoriasis sufferers and 100 million vitiligo sufferers

who rely on safe phototherapy solutions.

Commercial

Readiness & Multi-Channel Strategy

Caring

Brands is actively advancing operational and partner readiness to support expanded product availability. Building upon established international

partnerships, including licensing agreements with global leaders like Taisho Pharmaceutical, ongoing commercialization initiatives include:

● Coordination

of scalable third-party manufacturing and supply logistics.

● Alignment

of packaging, labeling, and regulatory compliance frameworks.

● Preparation

of comprehensive diligence materials for prospective licensees and regional distributors.

● Execution

of a hybrid commercial model anchored by primary B2B licensing partnerships and supplemented

by targeted direct-to-consumer (DTC) sales via Amazon and select retail channels.

“Building

Caring Brands around proprietary, science-backed solutions addressing immense clinical needs is central to our long-term value creation

model,” said Dr. Glynn Wilson, Chief Executive Officer of Caring Brands. “With five issued U.S. patents protecting our flagship

platforms across multi-billion-dollar hair care and dermatology markets, our immediate operational focus is translating this strong legal

foundation into scalable commercial opportunities, advancing operational readiness, empowering existing partners like Taisho, and securing

new licensing agreements globally.”

Caring

Brands plans to maintain and expand its intellectual property assets where commercially strategic, aligning future patent filings directly

with high-value product development priorities. Note: Patent issuance does not constitute regulatory approval, establish clinical efficacy,

or guarantee commercial success. The Company previously disclosed that it is not in compliance with the stockholders’ equity requirement

of Nasdaq Listing Rule 5550(b) and that the Nasdaq Staff issued a delisting determination, which the Company has appealed to a Hearings

Panel. There can be no assurance that the Company will regain compliance or that its securities will remain listed on Nasdaq. Investors

should read the Company’s filings with the SEC, including the risk factors therein, for a fuller description.

About

Caring Brands

Caring

Brands Inc. is a wellness consumer-products company developing over-the-counter and cosmetic products, including Hair Enzyme Booster,

Photocil, CB-101 and NoStingz.

Contact:

Brian

S John

Chief Investment Officer

(561) 896-7616

Forward-Looking

Statements

This

communication contains forward-looking statements regarding Caring Brands, Inc., including statements concerning the Company’s

intellectual property strategy, product development and commercialization, licensing opportunities and potential strategic relationships,

the Company’s ability to regain compliance with Nasdaq listing requirements and the outcome of the pending Hearings Panel proceeding,

and the activities and commercialization plans of the Company’s existing licensees. Forward-looking statements may be identified

by words such as “anticipate,” “believe,” “continue,” “could,” “estimate,”

“expect,” “explore,” “evaluate,” “intend,” “may,” “might,” “plan,”

“potential,” “project,” “seek,” “should” or “will,” and similar expressions.

These statements are based on the Company’s current plans, objectives, estimates and expectations and inherently involve risks

and uncertainties, many of which are beyond its control. Actual results and the timing of events could differ materially as a result

of these risks and uncertainties, including the outcome of patent prosecution; challenges involving patent validity, enforceability,

ownership or scope; regulatory developments; development and manufacturing risks; market acceptance; competition; access to capital;

and the other risks described under Item 1A, “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year

ended December 31, 2025, filed on March 31, 2026, and in its subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K,

available at www.sec.gov. Investors are cautioned that forward-looking statements are not guarantees of future performance. The statements

in this communication speak only as of the date made, and Caring Brands undertakes no obligation to update or supplement them, except

as required by law.

GRAPHIC

Filename: ex99-1_001.jpg · Sequence: 3

Binary file (2175 bytes)

Download ex99-1_001.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 8

v3.26.1

Cover

Aug. 06, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Aug. 06, 2026

Entity File Number

001-42941

Entity Registrant Name

Caring

Brands, Inc.

Entity Central Index Key

0002020737

Entity Tax Identification Number

99-4103908

Entity Incorporation, State or Country Code

Entity Address, Address Line One

130

S Indian River Drive

Entity Address, Address Line Two

Suite

202 pbm# 1232

Entity Address, City or Town

Fort

Pierce

Entity Address, State or Province

Entity Address, Postal Zip Code

34950

City Area Code

(561)

Local Phone Number

896-7616

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common

Stock, par value $0.001 per share

Trading Symbol

CABR

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration